Umphred-Wilson Katharine, Ratnayake Shashikala, Tang Qianzi, Wang Rui, Chaudhary Sneha Ghosh, Ballachanda Devaiah N, Trichka Josephine, Wisniewski Jan, Zhou Lan, Chen Qingrong, Meerzaman Daoud, Singer Dinah S, Adoro Stanley
Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Immunology Training Program, Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA.
Nat Commun. 2025 May 3;16(1):4133. doi: 10.1038/s41467-025-59504-9.
Addiction to oncogene-rewired transcriptional networks is a therapeutic vulnerability in cancer cells, underscoring a need to better understand mechanisms that relay oncogene signals to the transcriptional machinery. Here, using human and mouse T cell acute lymphoblastic leukemia (T-ALL) models, we identify an essential requirement for the endosomal sorting complex required for transport protein CHMP5 in T-ALL epigenetic and transcriptional programming. CHMP5 is highly expressed in T-ALL cells where it mediates recruitment of the coactivator BRD4 and the histone acetyl transferase p300 to enhancers and super-enhancers that enable transcription of T-ALL genes. Consequently, CHMP5 depletion causes severe downregulation of critical T-ALL genes, mitigates chemoresistance and impairs T-ALL initiation by oncogenic NOTCH1 in vivo. Altogether, our findings uncover a non-oncogene dependency on CHMP5 that enables T-ALL initiation and maintenance.
对癌基因重排转录网络的成瘾是癌细胞中的一种治疗脆弱性,这突出表明需要更好地理解将癌基因信号传递到转录机制的机制。在这里,我们使用人类和小鼠T细胞急性淋巴细胞白血病(T-ALL)模型,确定了转运蛋白CHMP5所需的内体分选复合物在T-ALL表观遗传和转录编程中的基本需求。CHMP5在T-ALL细胞中高度表达,它介导共激活因子BRD4和组蛋白乙酰转移酶p300募集到增强子和超级增强子,从而使T-ALL基因得以转录。因此,CHMP5的缺失会导致关键T-ALL基因的严重下调,减轻化疗耐药性,并在体内削弱致癌性NOTCH1引发T-ALL的能力。总之,我们的研究结果揭示了对CHMP5的非癌基因依赖性,这种依赖性能够启动和维持T-ALL。